Flinton Capital Management LLC increased its stake in shares of Humana Inc (NYSE:HUM) by 6.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 56,704 shares of the insurance provider’s stock after acquiring an additional 3,360 shares during the period. Flinton Capital Management LLC’s holdings in Humana were worth $16,877,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Synovus Financial Corp acquired a new stake in Humana during the first quarter worth about $100,000. Sun Life Financial INC grew its holdings in Humana by 120.7% during the second quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after acquiring an additional 204 shares during the period. Stratos Wealth Partners LTD. grew its holdings in Humana by 448.7% during the first quarter. Stratos Wealth Partners LTD. now owns 417 shares of the insurance provider’s stock worth $112,000 after acquiring an additional 341 shares during the period. Financial Gravity Wealth Inc. acquired a new stake in Humana in the first quarter valued at approximately $113,000. Finally, Migdal Insurance & Financial Holdings Ltd. grew its holdings in Humana by 2,984.6% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 388 shares during the period. 93.00% of the stock is currently owned by hedge funds and other institutional investors.
Several analysts have commented on HUM shares. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th. Citigroup reissued a “buy” rating and issued a $340.00 price objective (up from $280.00) on shares of Humana in a report on Friday, June 1st. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $326.00 price objective on the stock in a report on Monday, May 21st. Bank of America raised their price objective on Humana from $338.00 to $375.00 and gave the company a “buy” rating in a report on Thursday, August 2nd. Finally, Jefferies Financial Group raised their price objective on Humana from $356.00 to $372.00 and gave the company a “buy” rating in a report on Thursday, August 2nd. Six research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $328.94.
In other news, insider Elizabeth D. Bierbower sold 3,092 shares of the firm’s stock in a transaction that occurred on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total value of $1,020,360.00. Following the transaction, the insider now owns 14,289 shares in the company, valued at $4,715,370. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Cynthia H. Zipperle sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 13th. The shares were sold at an average price of $306.01, for a total value of $306,010.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 92,431 shares of company stock worth $28,602,805. Company insiders own 0.60% of the company’s stock.
NYSE HUM opened at $333.09 on Wednesday. The company has a market capitalization of $45.91 billion, a PE ratio of 28.44, a PEG ratio of 1.66 and a beta of 0.96. Humana Inc has a 1-year low of $231.90 and a 1-year high of $336.48. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.47.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, beating the consensus estimate of $3.79 by $0.17. The business had revenue of $14.26 billion for the quarter, compared to the consensus estimate of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same quarter last year, the business posted $3.49 earnings per share. research analysts predict that Humana Inc will post 14.18 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be given a $0.50 dividend. The ex-dividend date is Thursday, September 27th. This represents a $2.00 annualized dividend and a dividend yield of 0.60%. Humana’s dividend payout ratio (DPR) is presently 17.08%.
Humana Company Profile
Humana Inc is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.
Featured Story: Trading Strategy Methods for Individual Investors
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.